Clinomics Europe


Medical biotechnology company focused on liquid biopsy and precision medicine. Activities include development and distribution of molecular diagnostic assays and consumables, clinical laboratory testing (including SARS-CoV-2 testing), assay and biomarker R&D, bioinformatics for multi-omics data, academic collaborations, and operation of an in-house research laboratory in Hungary.

Industries

biotechnology
health-diagnostics
medical

Nr. of Employees

medium (51-250)


Products

Room-temperature stable molecular reagent kits

Lyophilized reagent kits for molecular detection designed for room-temperature storage and transport to support decentralized testing workflows.

Portable isothermal molecular diagnostic device and assay kits

Compact molecular test platform using isothermal amplification chemistry with visible/optical readout and mobile-device reporting designed for rapid detection of viral RNA and similar targets.

Methylation-based ctDNA diagnostic kits

Assay kits for multi-gene methylation detection intended for cancer screening or monitoring applications.

cfDNA collection and stabilization tubes

Sample collection devices for preservation and transport of cell-free DNA from blood for downstream molecular assays.


Services

Clinical and research laboratory testing services analyzing circulating tumor DNA, circulating tumor cells and extracellular vesicles to support diagnostic, prognostic and monitoring applications.

Provision and technical support for compact molecular testing platforms using isothermal amplification chemistry and mobile-device result reporting for decentralized testing use cases.

Commercial distribution, sales support, warranty handling and logistics for laboratory consumables, sample collection devices and diagnostic kits.

Data analysis and integration services for single-cell and cfDNA datasets to support biomarker discovery, longitudinal monitoring and clinical interpretation.

Expertise Areas

  • Liquid biopsy diagnostics
  • ctDNA methylation analysis
  • Circulating tumor cell enrichment and single-cell multi-omics
  • Biomarker discovery and assay development
  • Show More (6)

Key Technologies

  • Next-generation sequencing (NGS)
  • ctDNA methylation assays
  • Cell-free DNA fragmentomics
  • Single-cell RNA-seq and single-cell multi-omics
  • Show More (6)

News & Updates

Launch of the company's technical blog to explain liquid biopsy technologies and to provide educational content; invitation to subscribe to updates.

Membership in a multi-partner network focused on harmonization of liquid biopsy technologies, clinical study design and regulatory interaction.

Attendance and sponsorship of a national molecular life sciences conference to engage with academic and industry researchers.

Technical training collaboration with a molecular diagnostics laboratory partner in Evry, France.

Operation of the company's R&D laboratory within a university faculty facility in Hungary.

Overview of single-cell multi-omics approaches applied to circulating tumor cells, covering genomics, transcriptomics, proteomics and epigenomics and their application in personalized oncology.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.